Cita APA

Canyelles, M., Plaza, M., Rotllan, N., Llobet i Lorente, M. D., Julve, J., Mojal, S., . . . Souto Andrés, J. C. (2023). TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism.

Citación estilo Chicago

Canyelles, Marina, et al. TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated With Thrombotic Risk in Patients With Venous Thromboembolism. 2023.

Cita MLA

Canyelles, Marina, et al. TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated With Thrombotic Risk in Patients With Venous Thromboembolism. 2023.